Episode 79: Covid-19 vaccine rollout across the Asia-Pacific region
The Asia-Pacific region is well-placed in the coronavirus disease 2019 (COVID-19) vaccine rollout, with both India and China having sufficient domestic innovation and production capacity to be pivotal vaccine suppliers. Vaccine rollouts in most Asia-Pacific countries will likely extend into 2022 given supply constraints, logistical difficulties, the geographical spread of rural populations, and shortages of trained healthcare professionals. Join Lindsay Newman, Bree Neff, Sophie Cairns, and Deepa Kumar in today’s episode as they discuss the geopolitics of the vaccine rollout, vaccine development, and what this means for the recovery timeline.
Recommended for you
- Episode 91: Commodities may have reached their peak - Looking at the signals
- Episode 90: Implications for Mozambique’s insurgency in the northern Cabo Delgado province
- Episode 89: What’s next for the Central African Economic and Monetary Community (CEMAC) region?
- Episode 88: Supply chain issues compound as freight woes continue
- Episode 87: COVID-19 outbreak in India
- Episode 86: COVID-19 Vaccine rollout across the Middle East and North Africa
- Episode 85: Covid-19 vaccine rollout across Europe
- Episode 84: Lumber climbs sky-high